Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images

We compared the accuracy of prediction of the response to neoadjuvant chemotherapy (NAC) in osteosarcoma patients between machine learning approaches of whole tumor utilizing fluorine−<sup>18</sup>fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake heterogeneity features and a con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jingyu Kim, Su Young Jeong, Byung-Chul Kim, Byung-Hyun Byun, Ilhan Lim, Chang-Bae Kong, Won Seok Song, Sang Moo Lim, Sang-Keun Woo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/0b57af5f79e040f6b970464abd406295
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0b57af5f79e040f6b970464abd406295
record_format dspace
spelling oai:doaj.org-article:0b57af5f79e040f6b970464abd4062952021-11-25T17:20:25ZPrediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images10.3390/diagnostics111119762075-4418https://doaj.org/article/0b57af5f79e040f6b970464abd4062952021-10-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/1976https://doaj.org/toc/2075-4418We compared the accuracy of prediction of the response to neoadjuvant chemotherapy (NAC) in osteosarcoma patients between machine learning approaches of whole tumor utilizing fluorine−<sup>18</sup>fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake heterogeneity features and a convolutional neural network of the intratumor image region. In 105 patients with osteosarcoma, <sup>18</sup>F-FDG positron emission tomography/computed tomography (PET/CT) images were acquired before (baseline PET0) and after NAC (PET1). Patients were divided into responders and non-responders about neoadjuvant chemotherapy. Quantitative <sup>18</sup>F-FDG heterogeneity features were calculated using LIFEX version 4.0. Receiver operating characteristic (ROC) curve analysis of <sup>18</sup>F-FDG uptake heterogeneity features was used to predict the response to NAC. Machine learning algorithms and 2-dimensional convolutional neural network (2D CNN) deep learning networks were estimated for predicting NAC response with the baseline PET0 images of the 105 patients. ML was performed using the entire tumor image. The accuracy of the 2D CNN prediction model was evaluated using total tumor slices, the center 20 slices, the center 10 slices, and center slice. A total number of 80 patients was used for k-fold validation by five groups with 16 patients. The CNN network test accuracy estimation was performed using 25 patients. The areas under the ROC curves (AUCs) for baseline PET maximum standardized uptake value (SUVmax), total lesion glycolysis (TLG), metabolic tumor volume (MTV), and gray level size zone matrix (GLSZM) were 0.532, 0.507, 0.510, and 0.626, respectively. The texture features test accuracy of machine learning by random forest and support vector machine were 0.55 and 0. 54, respectively. The k-fold validation accuracy and validation accuracy were 0.968 ± 0.01 and 0.610 ± 0.04, respectively. The test accuracy of total tumor slices, the center 20 slices, center 10 slices, and center slices were 0.625, 0.616, 0.628, and 0.760, respectively. The prediction model for NAC response with baseline PET0 texture features machine learning estimated a poor outcome, but the 2D CNN network using <sup>18</sup>F-FDG baseline PET0 images could predict the treatment response before prior chemotherapy in osteosarcoma. Additionally, using the 2D CNN prediction model using a tumor center slice of <sup>18</sup>F-FDG PET images before NAC can help decide whether to perform NAC to treat osteosarcoma patients.Jingyu KimSu Young JeongByung-Chul KimByung-Hyun ByunIlhan LimChang-Bae KongWon Seok SongSang Moo LimSang-Keun WooMDPI AGarticle<sup>18</sup>F-FDG heterogeneityconvolutional neural networkchemotherapy responseosteosarcomamachine learningMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 1976, p 1976 (2021)
institution DOAJ
collection DOAJ
language EN
topic <sup>18</sup>F-FDG heterogeneity
convolutional neural network
chemotherapy response
osteosarcoma
machine learning
Medicine (General)
R5-920
spellingShingle <sup>18</sup>F-FDG heterogeneity
convolutional neural network
chemotherapy response
osteosarcoma
machine learning
Medicine (General)
R5-920
Jingyu Kim
Su Young Jeong
Byung-Chul Kim
Byung-Hyun Byun
Ilhan Lim
Chang-Bae Kong
Won Seok Song
Sang Moo Lim
Sang-Keun Woo
Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
description We compared the accuracy of prediction of the response to neoadjuvant chemotherapy (NAC) in osteosarcoma patients between machine learning approaches of whole tumor utilizing fluorine−<sup>18</sup>fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake heterogeneity features and a convolutional neural network of the intratumor image region. In 105 patients with osteosarcoma, <sup>18</sup>F-FDG positron emission tomography/computed tomography (PET/CT) images were acquired before (baseline PET0) and after NAC (PET1). Patients were divided into responders and non-responders about neoadjuvant chemotherapy. Quantitative <sup>18</sup>F-FDG heterogeneity features were calculated using LIFEX version 4.0. Receiver operating characteristic (ROC) curve analysis of <sup>18</sup>F-FDG uptake heterogeneity features was used to predict the response to NAC. Machine learning algorithms and 2-dimensional convolutional neural network (2D CNN) deep learning networks were estimated for predicting NAC response with the baseline PET0 images of the 105 patients. ML was performed using the entire tumor image. The accuracy of the 2D CNN prediction model was evaluated using total tumor slices, the center 20 slices, the center 10 slices, and center slice. A total number of 80 patients was used for k-fold validation by five groups with 16 patients. The CNN network test accuracy estimation was performed using 25 patients. The areas under the ROC curves (AUCs) for baseline PET maximum standardized uptake value (SUVmax), total lesion glycolysis (TLG), metabolic tumor volume (MTV), and gray level size zone matrix (GLSZM) were 0.532, 0.507, 0.510, and 0.626, respectively. The texture features test accuracy of machine learning by random forest and support vector machine were 0.55 and 0. 54, respectively. The k-fold validation accuracy and validation accuracy were 0.968 ± 0.01 and 0.610 ± 0.04, respectively. The test accuracy of total tumor slices, the center 20 slices, center 10 slices, and center slices were 0.625, 0.616, 0.628, and 0.760, respectively. The prediction model for NAC response with baseline PET0 texture features machine learning estimated a poor outcome, but the 2D CNN network using <sup>18</sup>F-FDG baseline PET0 images could predict the treatment response before prior chemotherapy in osteosarcoma. Additionally, using the 2D CNN prediction model using a tumor center slice of <sup>18</sup>F-FDG PET images before NAC can help decide whether to perform NAC to treat osteosarcoma patients.
format article
author Jingyu Kim
Su Young Jeong
Byung-Chul Kim
Byung-Hyun Byun
Ilhan Lim
Chang-Bae Kong
Won Seok Song
Sang Moo Lim
Sang-Keun Woo
author_facet Jingyu Kim
Su Young Jeong
Byung-Chul Kim
Byung-Hyun Byun
Ilhan Lim
Chang-Bae Kong
Won Seok Song
Sang Moo Lim
Sang-Keun Woo
author_sort Jingyu Kim
title Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
title_short Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
title_full Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
title_fullStr Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
title_full_unstemmed Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
title_sort prediction of neoadjuvant chemotherapy response in osteosarcoma using convolutional neural network of tumor center <sup>18</sup>f-fdg pet images
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/0b57af5f79e040f6b970464abd406295
work_keys_str_mv AT jingyukim predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT suyoungjeong predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT byungchulkim predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT byunghyunbyun predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT ilhanlim predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT changbaekong predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT wonseoksong predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT sangmoolim predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
AT sangkeunwoo predictionofneoadjuvantchemotherapyresponseinosteosarcomausingconvolutionalneuralnetworkoftumorcentersup18supffdgpetimages
_version_ 1718412451793338368